🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMetabolic Health & DiabetesA1C target achievement rates — looking for input Page 5

A1C target achievement rates — looking for input

SurmountFan_IN Fri, Jan 9, 2026 at 4:01 PM 30 replies 1,086 viewsPage 5 of 6
matt_MKE
Member
312
1,345
Sep 2024
Milwaukee, WI
Jan 18, 2026 at 9:28 AM#21

A narrower follow-up, since the general answer is now clear:

Was that from a primary source or from a summary of one?

36 9andrew_nyc, Dr.EndoEP, GraceAZ_72 and 33 others
Reply Quote Save Share Report
sarah_TO
Member
278
1,234
Sep 2024
Toronto, CA
Jan 21, 2026 at 9:29 AM#22
FDA_TrackerJim said:
It is worth asking what the claim would look like if it were false.

Filing a mild objection. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. Filing an objection on the n=1 problem. Personal experience is genuine evidence about one person and very weak evidence about anybody else, and this thread keeps promoting the first into the second.

37 10Dr.EndoEP, GraceAZ_72, carl_compliance and 34 others
Reply Quote Save Share Report
tom_AK
New Member
28
112
Jan 2026
Anchorage, AK
Jan 24, 2026 at 9:32 AM#23
FDA_TrackerJim said:
It is worth asking what the claim would look like if it were false.

No disagreement, though the timescale matters more than the mechanism here. Most of what looks like a difference in kind turns out to be a difference in how long somebody waited.

Last edited: Jan 24, 2026 at 1:32 PM
38 11tyler_CSCS, VanRx_Mike, steve_okc and 35 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
SallyK_inj
Member
567
2,345
Jul 2024
Iowa
Jan 27, 2026 at 9:37 AM#24
FDA_TrackerJim said:
It is worth asking what the claim would look like if it were false.

Saving this. It is the first explanation that did not require me to already understand it. Adding it to my notes with a link back to this thread.

Last edited: Jan 27, 2026 at 10:37 AM
39 12tane_welly, Dr.PathRoch, mona_PHX and 36 others
Reply Quote Save Share Report
claudia_zurich
Member
389
1,678
Jul 2024
Zurich, CH
Jan 30, 2026 at 9:44 AM#25

Clinical perspective, offered as context rather than as advice. Start from the measurement rather than the conclusion. Almost every disagreement here turns out to be two people measuring different things and comparing the numbers anyway.

40 13kevin_tulsa, Dr.PainCLE, mike_mealprep and 37 others
Reply Quote Save Share Report

Similar Threads

SUSTAIN-6 to SELECT — the cardiovascular evidence timeline14 replies
GLP-1 and insulin resistance — HOMA-IR improvement data17 replies
Metabolic syndrome reversal criteria — how GLP-1 addresses all 55 replies
A1C target achievement rates — sema vs tirz comparison8 replies
SURPASS-CVOT: tirzepatide cardiovascular outcomes trial design3 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register